Mereo Biopharma Group PLC
NASDAQ:MREO
Mereo Biopharma Group PLC
Cash from Financing Activities
Mereo Biopharma Group PLC
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mereo Biopharma Group PLC
NASDAQ:MREO
|
Cash from Financing Activities
-£780k
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash from Financing Activities
$21.1m
|
CAGR 3-Years
149%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash from Financing Activities
-$883k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash from Financing Activities
$250m
|
CAGR 3-Years
58%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash from Financing Activities
£34.3m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
221%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Cash from Financing Activities
-£20.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mereo Biopharma Group PLC's Cash from Financing Activities?
Cash from Financing Activities
-780k
GBP
Based on the financial report for Dec 31, 2022, Mereo Biopharma Group PLC's Cash from Financing Activities amounts to -780k GBP.
What is Mereo Biopharma Group PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
48%
The average annual Cash from Financing Activities growth rates for Mereo Biopharma Group PLC have been 48% over the past three years .